Fresenius reported 1.48B in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Akzo Nobel AKZA:NA 749M 37M
Alcon AG ALC:SW 734M 72M
AstraZeneca AZN:LN 3.06B 1.03B
BASF BAS:GR 2.59B 161M
Bayer BAYN:GR 3.94B 346M
Davita Healthcare Partners DVA:US $ 294.82M 27.9M
E.ON EOAN:GR 1.48B 170M
Fresenius FRE:GR 1.48B 10M
Fresenius Medical Care FME:GR 871.24M 48.03M
Fresenius Medical Care FMS:US 871.24M 48.03M
Getinge GETIB:SS 1.79B 67M
Givaudan GIVN:VX 564M 28M
GlaxoSmithKline GSK:LN 2.68B 227M
GN Store Nord GN:DC 1.44B 162M
GRIFOLS GRF:SM 249.86M 7.28M
Hikma Pharmaceutical HIK:LN 256M 24M
Merck MRK:GR 1.37B 172M
Novartis NOVN:VX 3.5B 486M
Philips PHIA:NA 1.22B 80M
William Demant Holding WDH:DC 4.64B 158M